{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Laboratory+testing&page=49", "query": { "intervention": "Laboratory testing", "page": 49 }, "page_size": 10 }, "pagination": { "page": 49, "page_size": 10, "total_count": 2413, "total_pages": 242, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Laboratory+testing&page=50&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Laboratory+testing&page=48&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-27T02:10:27.100Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04028479", "title": "The Registry of Oncology Outcomes Associated With Testing and Treatment", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Adenocarcinoma", "Adenocystic Carcinoma", "Anal Cancer", "Appendix Cancer", "Brain Tumor", "Glioblastoma", "Astrocytoma", "Bile Duct Cancer", "Cholangiocarcinoma", "Bladder Cancer", "Bone Cancer", "Synovial Sarcoma", "Chondrosarcoma", "Liposarcoma", "Sarcoma, Kaposi", "Sarcoma,Soft Tissue", "Sarcoma", "Osteosarcoma", "CNS Cancer", "Brain Stem Neoplasms", "Breast Cancer", "Cervical Cancer", "Colorectal Cancer", "Rectal Cancer", "Colon Cancer", "Esophageal Cancer", "Esophagus Cancer", "Cancer of Colon", "Pancreatic Cancer", "Cancer of Pancreas", "Testis Cancer", "Testicular Cancer", "Ureter Cancer", "Renal Cell Carcinoma", "Kidney Cancer", "Gestational Trophoblastic Tumor", "Head and Neck Neoplasms", "Parotid Tumor", "Larynx Cancer", "Tongue Cancer", "Pharynx Cancer", "Salivary Gland Cancer", "Acute Myeloid Leukemia", "Chronic Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Multiple Myeloma", "Non Hodgkin Lymphoma", "Carcinoid Tumor", "Lung Cancer", "Neuroendocrine Tumors", "Mesothelioma", "Thyroid Cancer", "Parathyroid Neoplasms", "Adrenal Cancer", "Small Bowel Cancer", "Stomach Cancer", "Liver Cancer", "Hepatic Cancer", "Melanoma", "Skin Cancer", "Unknown Primary Tumors", "Uterine Cancer", "Fallopian Tube Cancer", "Ovarian Cancer", "Prostate Cancer", "Vaginal Cancer", "Penile Cancer", "Vulvar Cancer", "Waldenstrom Macroglobulinemia", "Cancer, Advanced", "Thymus Cancer", "Nasopharyngeal Carcinoma", "Multiple Endocrine Neoplasia", "Pheochromocytoma", "Small Cell Carcinoma", "Pulmonary Carcinoma" ], "interventions": [ { "name": "Biomarker Testing (L)", "type": "DIAGNOSTIC_TEST" }, { "name": "Systemic Treatment (T)", "type": "DRUG" }, { "name": "Patient Reported Outcomes (P)", "type": "OTHER" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "DRUG", "OTHER" ], "sponsor": "Taproot Health", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 167, "start_date": "2021-05-05", "completion_date": "2024-10-31", "has_results": false, "last_update_posted_date": "2024-12-18", "last_synced_at": "2026-10-27T02:10:27.100Z", "location_count": 2, "location_summary": "Idaho Falls, Idaho • Laredo, Texas", "locations": [ { "city": "Idaho Falls", "state": "Idaho" }, { "city": "Laredo", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04028479" }, { "nct_id": "NCT04598035", "title": "Epidural Spinal Cord Stimulation for Hypertension in Patients With Neuropathic Pain", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Pain", "Hypertension", "Implanted Stimulation Electrodes" ], "interventions": [ { "name": "Diagnostic Tests", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "30 Years to 89 Years" }, "enrollment_count": 72, "start_date": "2020-11-01", "completion_date": "2025-11-01", "has_results": false, "last_update_posted_date": "2025-08-07", "last_synced_at": "2026-10-27T02:10:27.100Z", "location_count": 2, "location_summary": "Fairway, Kansas • Kansas City, Kansas", "locations": [ { "city": "Fairway", "state": "Kansas" }, { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04598035" }, { "nct_id": "NCT02160678", "title": "Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Vehicle", "type": "DRUG" }, { "name": "Tazarotene Cream, 0.1 %", "type": "DRUG" }, { "name": "Tazorac Cream, 0.1%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "G & W Laboratories Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "12 Years to 40 Years" }, "enrollment_count": 1741, "start_date": "2014-05", "completion_date": "2015-07", "has_results": false, "last_update_posted_date": "2016-11-03", "last_synced_at": "2026-10-27T02:10:27.100Z", "location_count": 1, "location_summary": "Arlington Hts., Illinois", "locations": [ { "city": "Arlington Hts.", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02160678" }, { "nct_id": "NCT01446458", "title": "Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cancer of Pancreas", "Cancer of the Pancreas", "Neoplasms, Pancreatic", "Pancreas Cancer", "Pancreas Neoplasms" ], "interventions": [ { "name": "Modified FOLFIRINOX", "type": "DRUG" }, { "name": "Stereotactic Body Radiotherapy (SBRT)", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 13, "start_date": "2011-11", "completion_date": "2015-03", "has_results": false, "last_update_posted_date": "2016-03-22", "last_synced_at": "2026-10-27T02:10:27.100Z", "location_count": 2, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01446458" }, { "nct_id": "NCT01699763", "title": "Evaluation of Blood Glucose Monitoring Systems", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes" ], "interventions": [ { "name": "Contour® NEXT LINK BGMS", "type": "DEVICE" }, { "name": "OneTouch® UltraLink® BGMS", "type": "DEVICE" }, { "name": "Nova Max Link® BGMS", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Ascensia Diabetes Care", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 112, "start_date": "2012-10", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2016-02-29", "last_synced_at": "2026-10-27T02:10:27.100Z", "location_count": 1, "location_summary": "Mishawaka, Indiana", "locations": [ { "city": "Mishawaka", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01699763" }, { "nct_id": "NCT02653443", "title": "A Randomized, Multi-center, Open-label, Paired Controlled, Crossover In Vivo Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Autologous apheresis Platelet Components, prepared with the INTERCEPT Blood System for Platelets.", "type": "BIOLOGICAL" }, { "name": "Autologous apheresis Conventional untreated Platelet Components", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Cerus Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2015-12", "completion_date": "2016-05", "has_results": false, "last_update_posted_date": "2018-01-26", "last_synced_at": "2026-10-27T02:10:27.100Z", "location_count": 2, "location_summary": "Lebanon, New Hampshire • Cincinnati, Ohio", "locations": [ { "city": "Lebanon", "state": "New Hampshire" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02653443" }, { "nct_id": "NCT06965114", "title": "Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hairy Cell Leukemia", "Recurrent Hairy Cell Leukemia", "Refractory Hairy Cell Leukemia" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Cladribine", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Rituximab", "type": "BIOLOGICAL" }, { "name": "Tovorafenib", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 84, "start_date": "2026-05-29", "completion_date": "2030-03-01", "has_results": false, "last_update_posted_date": "2026-07-31", "last_synced_at": "2026-10-27T02:10:27.100Z", "location_count": 4, "location_summary": "Bethesda, Maryland • Columbus, Ohio • Pittsburgh, Pennsylvania + 1 more", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06965114" }, { "nct_id": "NCT03676816", "title": "Self Sampling for Rapid Turnaround Testing in the Emergency Department", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chlamydia Trachomatis", "Neisseria Gonorrhoeae" ], "interventions": [ { "name": "vaginal self sampling", "type": "PROCEDURE" }, { "name": "provider-performed endocervical sampling", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 533, "start_date": "2018-09-17", "completion_date": "2020-06-09", "has_results": false, "last_update_posted_date": "2021-08-05", "last_synced_at": "2026-10-27T02:10:27.100Z", "location_count": 1, "location_summary": "Fresno, California", "locations": [ { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03676816" }, { "nct_id": "NCT03871816", "title": "A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Metastatic Prostate Cancer" ], "interventions": [ { "name": "Saliva, Blood, or and/or Archival Tumor Tissue Collection and Analysis", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 14532, "start_date": "2019-04-22", "completion_date": "2022-11-22", "has_results": false, "last_update_posted_date": "2023-12-11", "last_synced_at": "2026-10-27T02:10:27.100Z", "location_count": 93, "location_summary": "Homewood, Alabama • Mobile, Alabama • Phoenix, Arizona + 82 more", "locations": [ { "city": "Homewood", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03871816" }, { "nct_id": "NCT04998006", "title": "Alcohol and Cannabis Co-Use and the Gut-Brain Axis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cannabis Use", "Alcohol Use", "Inflammation" ], "interventions": [], "intervention_types": [], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "21 Years to 60 Years" }, "enrollment_count": 77, "start_date": "2022-02-25", "completion_date": "2024-12-23", "has_results": false, "last_update_posted_date": "2026-05-15", "last_synced_at": "2026-10-27T02:10:27.100Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04998006" } ] }